Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Mar;51(3):335–345. doi: 10.1038/bjc.1985.45

Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism.

R Jacubovich, H Cabrillat, D Gerlier, M Bailly, J F Doré
PMCID: PMC1976943  PMID: 3882112

Abstract

Ten human melanoma cell lines (HMCL) were tested for their ability to grow subcutaneously in nude mice. Using a standard inoculum, the HMCL could be characterized by their highly, fairly or poorly xenografting phenotype. These phenotypes were stable and the phenotype of one HMCL was recovered within cell clones derived from it. The role of nude mice natural defences in the expression of HMCL xenografting phenotypes was studied. Sublethal whole body irradiation and silica pretreatment of recipients enabled poorly tumourigenic HMCL to grow in most animals without affecting their splenic NK activity. Admixture of BCG or MDP encapsulated in liposomes with highly tumourigenic HMCL resulted in the abrogation of tumour growth in naive nude mice. The long lasting abrogating of NK activity in vivo by treatment with anti-asialo-GM1 anti-serum did not enhance the growth of a poorly tumourigenic HMCL. The HMCL were found to be resistant to in vitro murine NK activity. These results showed that the expression of the HMCL xenografting phenotypes could be controlled by the nude mice natural defences. NK cells did not seem to be largely involved whereas macrophages might be good candidates as anti-xenograft effectors.

Full text

PDF
335

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Harington J. S., Birbeck M. An examination of the cytotoxic effects of silica on macrophages. J Exp Med. 1966 Aug 1;124(2):141–154. doi: 10.1084/jem.124.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bakouche O., Gerlier D. Physical separation of the aqueous phase and lipoidal lamellae from multilamellar liposomes: an analytical and preparative procedure. Anal Biochem. 1983 Apr 15;130(2):379–384. doi: 10.1016/0003-2697(83)90603-6. [DOI] [PubMed] [Google Scholar]
  3. Epstein A. L., Herman M. M., Kim H., Dorfman R. F., Kaplan H. S. Biology of the human malignant lymphomas. III. Intracranial heterotransplantation in the nude, athymic mouse. Cancer. 1976 May;37(5):2158–2176. doi: 10.1002/1097-0142(197605)37:5<2158::aid-cncr2820370503>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  4. Fidler I. J., Barnes Z., Fogler W. E., Kirsh R., Bugelski P., Poste G. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res. 1982 Feb;42(2):496–501. [PubMed] [Google Scholar]
  5. Fogh J., Fogh J. M., Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst. 1977 Jul;59(1):221–226. doi: 10.1093/jnci/59.1.221. [DOI] [PubMed] [Google Scholar]
  6. Gerlier D., Bakouche O., Dore J. F. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen. J Immunol. 1983 Jul;131(1):485–490. [PubMed] [Google Scholar]
  7. Gershwin M. E., Ikeda R. M., Erickson K., Owens R. Enhancement of heterotransplanted human tumor graft survival in nude mice treated with antilymphocyte serum and in congenitally athymic-asplenic (Lasat) mice. J Natl Cancer Inst. 1978 Jul;61(1):245–248. doi: 10.1093/jnci/61.1.245. [DOI] [PubMed] [Google Scholar]
  8. Gershwin M. E., Ikeda R. M., Kawakami T. G., Owens R. B. Immunobiology of heterotransplanted human tumors in nude mice. J Natl Cancer Inst. 1977 May;58(5):1455–1461. doi: 10.1093/jnci/58.5.1455. [DOI] [PubMed] [Google Scholar]
  9. Giovanella B. C., Stehlin J. S., Jr, Williams L. J., Jr, Lee S. S., Shepard R. C. Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy. Cancer. 1978 Nov;42(5):2269–2281. doi: 10.1002/1097-0142(197811)42:5<2269::aid-cncr2820420527>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  10. Hanna N., Fidler I. J. Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice. Cancer Res. 1981 Feb;41(2):438–444. [PubMed] [Google Scholar]
  11. Hanna N., Schneider M. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. J Immunol. 1983 Feb;130(2):974–980. [PubMed] [Google Scholar]
  12. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  13. Jacubovich R., Cabrillat H., Dore J. F. Natural resistance to xenografts of human malignant melanoma cell lines in nude mice. Absence of demonstrated role of NK activities. Exp Cell Biol. 1984;52(1-2):48–52. [PubMed] [Google Scholar]
  14. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  15. Kawase I., Urdal D. L., Brooks C. G., Henney C. S. Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants. Int J Cancer. 1982 May 15;29(5):567–574. doi: 10.1002/ijc.2910290513. [DOI] [PubMed] [Google Scholar]
  16. MacDonald H. R. Phenotypic and functional characteristics of 'T-like' cells in nude mice. Exp Cell Biol. 1984;52(1-2):2–6. [PubMed] [Google Scholar]
  17. Minato N., Bloom B. R., Jones C., Holland J., Reid L. M. Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med. 1979 May 1;149(5):1117–1133. doi: 10.1084/jem.149.5.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morahan P. S., Kaplan A. M. Macrophage activation and anti-tumor activity of biologic and synthetic agents. Int J Cancer. 1976 Jan 15;17(1):82–89. doi: 10.1002/ijc.2910170112. [DOI] [PubMed] [Google Scholar]
  19. Ohsugi Y., Gershwin M. E., Owens R. B., Nelson-Rees W. A. Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice. J Natl Cancer Inst. 1980 Oct;65(4):715–718. doi: 10.1093/jnci/65.4.715. [DOI] [PubMed] [Google Scholar]
  20. Olstad R., Kaplan G., Seljelid R. In vitro cytotoxicity of mouse macrophages activated by coculture with syngeneic sarcoma cells. Scand J Immunol. 1982 Nov;16(5):421–430. doi: 10.1111/j.1365-3083.1982.tb00742.x. [DOI] [PubMed] [Google Scholar]
  21. Puccetti P., Santoni A., Riccardi C., Holden H. T., Herberman R. B. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity. Int J Cancer. 1979 Dec 15;24(6):819–825. doi: 10.1002/ijc.2910240621. [DOI] [PubMed] [Google Scholar]
  22. Reid L. M., Stiles C. D., Saier M. H., Jr, Rindler M. J. Growth of nontumorigenic cells in Millipore diffusion chambers implanted in mice and implications for in vivo growth regulation. Cancer Res. 1979 May;39(5):1467–1473. [PubMed] [Google Scholar]
  23. Reynolds C. W., Brunda M. J., Holden H. T., Herberman R. B. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities. J Natl Cancer Inst. 1981 May;66(5):837–842. [PubMed] [Google Scholar]
  24. Riccardi C., Puccetti P., Santoni A., Herberman R. B. Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst. 1979 Oct;63(4):1041–1045. [PubMed] [Google Scholar]
  25. Riccardi C., Santoni A., Barlozzari T., Cesarinin C., Herberman R. B. Suppression of natural killer (NK) activity by splenic adherent cells of low NK-reactive mice. Int J Cancer. 1981 Dec;28(6):811–818. doi: 10.1002/ijc.2910280621. [DOI] [PubMed] [Google Scholar]
  26. Schneider E. L., Stanbridge E. J., Epstein C. J. Incorporation of 3H-uridine and 3H-uracil into RNA: a simple technique for the detection of mycoplasma contamination of cultured cells. Exp Cell Res. 1974 Mar 15;84(1):311–318. doi: 10.1016/0014-4827(74)90411-x. [DOI] [PubMed] [Google Scholar]
  27. Schorlemmer H. U., Bosslet K., Sedlacek H. H. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. Cancer Res. 1983 Sep;43(9):4148–4153. [PubMed] [Google Scholar]
  28. Schroit A. J., Fidler I. J. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res. 1982 Jan;42(1):161–167. [PubMed] [Google Scholar]
  29. Sebesteny A., Taylor-Papadimitriou J., Ceriani R., Millis R., Schmitt C., Trevan D. Primary human breast carcinomas transplantable in the nude mouse. J Natl Cancer Inst. 1979 Dec;63(6):1331–1337. [PubMed] [Google Scholar]
  30. Sharkey F. E., Fogh J. Metastasis of human tumors in athymic nude mice. Int J Cancer. 1979 Dec 15;24(6):733–738. doi: 10.1002/ijc.2910240605. [DOI] [PubMed] [Google Scholar]
  31. Stiles C. D., Desmond W., Chuman L. M., Sato G., Saier M. H., Jr Relationship of cell growth behavior in vitro to tumorigenicity in athymic nude mice. Cancer Res. 1976 Sep;36(9 PT1):3300–3305. [PubMed] [Google Scholar]
  32. Thomasset N., Quash G., Doré J. F. Diamine oxidase activity in human melanoma cell lines with different tumorigenicity in nude mice. Br J Cancer. 1982 Jul;46(1):58–66. doi: 10.1038/bjc.1982.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tveit K. M., Pihl A. Do cell lines in vitro reflect the properties of the tumours of origin? A study of lines derived from human melanoma xenografts. Br J Cancer. 1981 Dec;44(6):775–786. doi: 10.1038/bjc.1981.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Uenishi N., Ida N., Kajita A., Usuki K. Host-mediated antitumor effect of interferon in nude mice transplanted with human tumor. Gan. 1983 Oct;74(5):730–736. [PubMed] [Google Scholar]
  35. Walker M. J., Chaudhuri P. K., Das Gupta T. K., Beattie C. W. Influence of host sex on the growth of human melanoma. Proc Soc Exp Biol Med. 1980 Oct;165(1):96–99. doi: 10.3181/00379727-165-40940. [DOI] [PubMed] [Google Scholar]
  36. Watanabe S., Shimosato Y., Kameya T., Kuroki M., Kitahara T., Minato K., Shimoyama M. Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa strain) in nude mice conditioned with whole-body irradiation. Cancer Res. 1978 Oct;38(10):3494–3498. [PubMed] [Google Scholar]
  37. White L., Meyer P. R., Benedict W. F. Establishment and characterization of a human T-cell leukemia line (LALW-2) in nude mice. J Natl Cancer Inst. 1984 May;72(5):1029–1038. [PubMed] [Google Scholar]
  38. Wolfe S. A., Tracey D. E., Henney C. S. Introduction of "natural" killer' cells by BCG. Nature. 1976 Aug 12;262(5569):584–586. doi: 10.1038/262584a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES